-
1
-
-
77956154899
-
Randomized controlled trial to investigate the effects of a newly developed formulation of phentermine diffuse-controlled release for obesity.
-
Kang JG, Park CY, Kang JH, Park YW, Park SW. Randomized controlled trial to investigate the effects of a newly developed formulation of phentermine diffuse-controlled release for obesity. Diabetes Obes Metab 2010; 12: 876-882.
-
(2010)
Diabetes Obes Metab
, vol.12
, pp. 876-882
-
-
Kang, J.G.1
Park, C.Y.2
Kang, J.H.3
Park, Y.W.4
Park, S.W.5
-
2
-
-
70349695858
-
Long-term weight loss from lifestyle intervention benefits blood pressure? a systematic review
-
Aucott L, Rothnie H, McIntyre L, Thapa M, Waweru C, Gray D. Long-term weight loss from lifestyle intervention benefits blood pressure? a systematic review. Hypertension 2009; 54: 756-762.
-
(2009)
Hypertension
, vol.54
, pp. 756-762
-
-
Aucott, L.1
Rothnie, H.2
McIntyre, L.3
Thapa, M.4
Waweru, C.5
Gray, D.6
-
3
-
-
78649644149
-
Treatment of obesity with "combination" pharmacotherapy.
-
Rothman RB. Treatment of obesity with "combination" pharmacotherapy. Am J Ther 2010; 17: 596-603.
-
(2010)
Am J Ther
, vol.17
, pp. 596-603
-
-
Rothman, R.B.1
-
4
-
-
81855194456
-
Blood pressure and heart rate effects, weight loss and maintenance during long-term phentermine pharmacotherapy for obesity.
-
Epub ahead of print].
-
Hendricks EJ, Greenway FL, Westman EC, Gupta AK. Blood pressure and heart rate effects, weight loss and maintenance during long-term phentermine pharmacotherapy for obesity. Obesity (Silver Spring) 2011 [Epub ahead of print].
-
(2011)
Obesity (Silver Spring)
-
-
Hendricks, E.J.1
Greenway, F.L.2
Westman, E.C.3
Gupta, A.K.4
-
5
-
-
79954561234
-
Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial.
-
Gadde KM, Allison DB, Ryan DH et al. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial. Lancet 2011; 377: 1341-1352.
-
(2011)
Lancet
, vol.377
, pp. 1341-1352
-
-
Gadde, K.M.1
Allison, D.B.2
Ryan, D.H.3
-
6
-
-
24644477445
-
Anorectics on trial: a half century of federal regulation of prescription appetite suppressants.
-
Colman E. Anorectics on trial: a half century of federal regulation of prescription appetite suppressants. Ann Intern Med 2005; 143: 380-385.
-
(2005)
Ann Intern Med
, vol.143
, pp. 380-385
-
-
Colman, E.1
-
7
-
-
0026593859
-
Long-term weight control study: conclusions.
-
Weintraub M. Long-term weight control study: conclusions. Clin Pharmacol Ther 1992; 51: 642-646.
-
(1992)
Clin Pharmacol Ther
, vol.51
, pp. 642-646
-
-
Weintraub, M.1
-
8
-
-
0017083601
-
Anorectic drugs: use in general practice.
-
Craddock D. Anorectic drugs: use in general practice. Drugs 1976; 11: 378-393.
-
(1976)
Drugs
, vol.11
, pp. 378-393
-
-
Craddock, D.1
-
9
-
-
69749110806
-
How physician obesity specialists use drugs to treat obesity.
-
Hendricks EJ, Rothman RB, Greenway FL. How physician obesity specialists use drugs to treat obesity. Obesity 2009; 17: 1730-1735.
-
(2009)
Obesity
, vol.17
, pp. 1730-1735
-
-
Hendricks, E.J.1
Rothman, R.B.2
Greenway, F.L.3
|